STEVENAGE, England--(BUSINESS WIRE)--Novella Clinical, Inc., a full service contract research organisation, today announced Elizabeth Edwards has been named vice president of operations for Europe. In this new role Edwards will be responsible for Novella’s clinical research and operations in the United Kingdom and mainland Europe.
With over 17 years experience in clinical development and operations, Elizabeth was most recently with Inspire Pharmaceuticals where she was senior director of clinical development. During her tenure she worked extensively in Eastern Europe, New Zealand and Australia while leading a global cross-functional team. Previously she held senior positions with GlaxoSmithKline Pharmaceuticals and Edwards Pharmaceutical Research.
“Elizabeth brings a tremendous amount of clinical knowledge and operational acumen to Novella,” said Rob King, chief operating officer for Novella Clinical. “Her direction will prove invaluable as we continue to expand our international operations and support our clients conducting global trials,” King added.
Novella’s more than 800 global professionals provide a full range of clinical research outsourcing solutions as well as flexible resourcing models for biopharmaceutical, oncology and medical device companies. With staff currently supporting clients in 19 European countries, Novella continues to expand throughout the EU.
About Novella Clinical
Novella Clinical, Inc. is a full service contract research organization with European headquarters in Stevenage, England. For more than a decade, Novella has served as an active partner to the oncology, biopharma and medical device industries. As the first global eCRO, Novella integrates deep clinical expertise with industry-leading technologies and a proven approach to support, streamline and expertly resource the entire product development process. For more information, visit www.novellaclinical.com.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50014435&lang=en